| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
21,110,000 |
| Market
Cap: |
5.48(M) |
| Last
Volume: |
4,769,812 |
Avg
Vol: |
4,756,909 |
| 52
Week Range: |
$0.2598 - $0.2598 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Plus Therapeutics is a clinical-stage pharmaceutical company focused on the development, manufacture and commercialization of treatments for patients battling cancer and other life-threatening diseases. The clinical stage drugs in Co.'s pipeline are: Rhenium NanoLiposomes, a radiotherapy for patients with recurrent glioblastoma; DocePLUS™, a chemotherapy for patients with tumors that has been evaluated in a completed U.S. single-center Phase 1 clinical trial; and DoxoPLUS™, a generic chemotherapy that has been evaluated in a completed, bioequivalence clinical trial in the U.S., Canada, and Ukraine versus Janssen's CAELYX® in patients with ovarian cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
48,285 |
48,285 |
99,872 |
103,373 |
| Total Buy Value |
$98,501 |
$98,501 |
$181,784 |
$195,866 |
| Total People Bought |
6 |
6 |
6 |
6 |
| Total Buy Transactions |
6 |
6 |
16 |
19 |
| Total Shares Sold |
0 |
0 |
2,068 |
3,568 |
| Total Sell Value |
$0 |
$0 |
$4,053 |
$4,525 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
1 |
2 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cox Marshall G |
officerTitle |
– • – |
2005-11-29 |
4 |
S |
$8.22 |
$172,267 |
D/D |
(20,957) |
521,659 |
|
- |
|
| Cox Marshall G |
Director |
– • – |
2005-11-18 |
4 |
S |
$8.70 |
$110,150 |
D/D |
(12,500) |
542,616 |
|
- |
|
| Cox Marshall G |
Director |
– • – |
2005-11-17 |
4 |
S |
$8.96 |
$89,600 |
D/D |
(10,000) |
542,616 |
|
- |
|
| Cox Marshall G |
Director |
– • – |
2005-09-27 |
4 |
OE |
$2.25 |
$190,630 |
D/D |
69,099 |
565,116 |
|
- |
|
| Olympus Corp |
10% Owner |
– – • |
2005-05-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,100,000 |
|
- |
|
| Calhoun Christopher J |
Chief Executive Officer |
• • – |
2004-11-18 |
4 |
S |
$3.00 |
$150,000 |
I/I |
(50,000) |
100,000 |
|
- |
|
| Saad Mark E |
Chief Financial Officer |
• – – |
2004-11-18 |
4 |
B |
$3.00 |
$150,000 |
D/D |
50,000 |
50,000 |
2.74 |
- |
|
| Calhoun Christopher J |
Chief Executive Officer |
• • – |
2004-06-08 |
4 |
S |
$3.79 |
$568,500 |
I/I |
(150,000) |
150,000 |
|
- |
|
| Cox Marshall G |
Director |
– • – |
2003-12-09 |
4 |
S |
$3.71 |
$556,500 |
D/D |
(150,000) |
496,017 |
|
- |
|
| Hedrick Marc H |
Chief Scientific Officer |
• • – |
2003-12-09 |
4 |
S |
$3.71 |
$92,750 |
D/D |
(25,000) |
410,525 |
|
- |
|
| Calhoun Christopher J |
President/CEO |
• • – |
2003-12-08 |
4 |
S |
$3.72 |
$744,000 |
I/I |
(200,000) |
300,000 |
|
- |
|
| Holmes E Carmack |
Director |
– • – |
2003-08-11 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
13,161 |
|
- |
|
| Holmes E Carmack |
Director |
– • – |
2003-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,845 |
|
- |
|
| Rickey David |
Director |
– • – |
2003-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,391) |
27,609 |
|
- |
|
| Rickey David |
Director |
– • – |
2003-07-02 |
4 |
OE |
$0.45 |
$22,500 |
D/D |
50,000 |
50,000 |
|
- |
|
340 Records found
|
|
Page 14 of 14 |
|
|
